Orbita, a provider of voice-first software for connected home healthcare, announced a collaboration with ERT to research innovative new approaches to data procurement and management for pharmaceutical and device customers seeking to streamline clinical trials. The collaboration combines the advanced capabilities of ERT’s EXPERT technology platform for clinical trial data collection, processing, and analysis with Orbita Voice, a first-of-its-kind solution for creating conversational applications using intelligent voice agents such as Amazon Alexa and Google Assistant.
CROS NT launches RaveX as part of Medidata extended partnership
IBM, tranSMART Foundation bring translational medicine data to scientists
ERT launches Solution for Lung Clearance Index (LCI)
Inmedix establishes subsidiary Inmedix UK, Ltd.
The Pulse on Technology by Elisa Cascade
We all know there is an issue surrounding investigator participation in industry-sponsored clinical trials. Tufts University puts the figure for doctors declining to return for a second study at approximately 40%. At the same time, the number of global clinical trials continues to rise and increase in complexity. We’ve all read articles and attended conferences that expound the passionate view that investigators who commit their time and expertise need our help and encouragement. But if that’s the case, why do we as an industry fail to address the administrative burdens driving them away?
Awards & Advancement
Tonix Pharmaceuticals Presented Analyses of Potential Moderators of Treatment Response to U.S. FDA-Designated Breakthrough Therapy for PTSD, TNX-102 SL, in Phase 2 AtEase Study in Military-Related PTSD